US Stock MarketDetailed Quotes

BioCardia (BCDA)

Watchlist
  • 1.400
  • 0.0000.00%
Close Jan 16 16:00 ET
  • 1.350
  • -0.050-3.57%
Post 20:01 ET
14.86MMarket Cap-0.99P/E (TTM)

BioCardia (BCDA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
-87.84%58K
0
0
-93.02%3K
-14.06%55K
-64.72%477K
-87.74%13K
Operating revenue
--0
--0
--0
-87.84%58K
--0
--0
-93.02%3K
-14.06%55K
-64.72%477K
-87.74%13K
Cost of revenue
Gross profit
Operating expense
-15.26%1.49M
24.15%2.05M
17.00%2.73M
-33.51%8.06M
10.68%2.32M
-40.58%1.76M
-52.73%1.65M
-34.81%2.33M
-8.54%12.12M
-32.87%2.1M
Selling and administrative expenses
-33.09%552K
-19.84%683K
9.83%1.2M
-16.45%3.67M
-3.72%906K
-23.82%825K
-27.86%852K
-8.49%1.09M
-0.54%4.4M
1.84%941K
Research and development costs
0.54%936K
71.00%1.37M
23.29%1.53M
-43.22%4.39M
22.40%1.42M
-50.27%931K
-65.43%800K
-47.94%1.24M
-12.54%7.73M
-47.45%1.16M
Operating profit
15.26%-1.49M
-24.38%-2.05M
-19.82%-2.73M
31.29%-8M
-11.37%-2.32M
32.41%-1.76M
52.23%-1.65M
35.19%-2.28M
2.16%-11.64M
30.95%-2.08M
Net non-operating interest income expense
Other net income (expense)
-73.68%5K
-33.33%2K
75.00%14K
-24.66%55K
108.33%25K
-20.83%19K
-89.29%3K
-11.11%8K
1,316.67%73K
220.00%12K
Other non- operating income (expenses)
-73.68%5K
-33.33%2K
75.00%14K
-24.66%55K
108.33%25K
-20.83%19K
-89.29%3K
-11.11%8K
1,316.67%73K
220.00%12K
Income before tax
14.62%-1.48M
-24.48%-2.05M
-19.63%-2.71M
31.33%-7.95M
-10.81%-2.3M
32.52%-1.74M
51.93%-1.65M
35.25%-2.27M
2.82%-11.57M
31.57%-2.07M
Income tax
Net income
14.62%-1.48M
-24.48%-2.05M
-19.63%-2.71M
31.33%-7.95M
-10.81%-2.3M
32.52%-1.74M
51.93%-1.65M
35.25%-2.27M
2.82%-11.57M
31.57%-2.07M
Net income continuous Operations
14.62%-1.48M
-24.48%-2.05M
-19.63%-2.71M
31.33%-7.95M
-10.81%-2.3M
32.52%-1.74M
51.93%-1.65M
35.25%-2.27M
2.82%-11.57M
31.57%-2.07M
Minority interest income
Net income attributable to the parent company
14.62%-1.48M
-24.48%-2.05M
-19.63%-2.71M
31.33%-7.95M
-10.81%-2.3M
32.52%-1.74M
51.93%-1.65M
35.25%-2.27M
2.82%-11.57M
31.57%-2.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.62%-1.48M
-24.48%-2.05M
-19.63%-2.71M
31.33%-7.95M
-10.81%-2.3M
32.52%-1.74M
51.93%-1.65M
35.25%-2.27M
2.82%-11.57M
31.57%-2.07M
Basic earnings per share
60.66%-0.24
54.55%-0.4
56.30%-0.59
64.59%-2.9
62.19%-0.499
65.92%-0.61
65.08%-0.88
47.06%-1.35
18.51%-8.19
45.00%-1.32
Diluted earnings per share
60.66%-0.24
54.55%-0.4
56.30%-0.59
64.59%-2.9
62.19%-0.499
65.92%-0.61
65.08%-0.88
47.06%-1.35
18.51%-8.19
45.00%-1.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 000-87.84%58K00-93.02%3K-14.06%55K-64.72%477K-87.74%13K
Operating revenue --0--0--0-87.84%58K--0--0-93.02%3K-14.06%55K-64.72%477K-87.74%13K
Cost of revenue
Gross profit
Operating expense -15.26%1.49M24.15%2.05M17.00%2.73M-33.51%8.06M10.68%2.32M-40.58%1.76M-52.73%1.65M-34.81%2.33M-8.54%12.12M-32.87%2.1M
Selling and administrative expenses -33.09%552K-19.84%683K9.83%1.2M-16.45%3.67M-3.72%906K-23.82%825K-27.86%852K-8.49%1.09M-0.54%4.4M1.84%941K
Research and development costs 0.54%936K71.00%1.37M23.29%1.53M-43.22%4.39M22.40%1.42M-50.27%931K-65.43%800K-47.94%1.24M-12.54%7.73M-47.45%1.16M
Operating profit 15.26%-1.49M-24.38%-2.05M-19.82%-2.73M31.29%-8M-11.37%-2.32M32.41%-1.76M52.23%-1.65M35.19%-2.28M2.16%-11.64M30.95%-2.08M
Net non-operating interest income expense
Other net income (expense) -73.68%5K-33.33%2K75.00%14K-24.66%55K108.33%25K-20.83%19K-89.29%3K-11.11%8K1,316.67%73K220.00%12K
Other non- operating income (expenses) -73.68%5K-33.33%2K75.00%14K-24.66%55K108.33%25K-20.83%19K-89.29%3K-11.11%8K1,316.67%73K220.00%12K
Income before tax 14.62%-1.48M-24.48%-2.05M-19.63%-2.71M31.33%-7.95M-10.81%-2.3M32.52%-1.74M51.93%-1.65M35.25%-2.27M2.82%-11.57M31.57%-2.07M
Income tax
Net income 14.62%-1.48M-24.48%-2.05M-19.63%-2.71M31.33%-7.95M-10.81%-2.3M32.52%-1.74M51.93%-1.65M35.25%-2.27M2.82%-11.57M31.57%-2.07M
Net income continuous Operations 14.62%-1.48M-24.48%-2.05M-19.63%-2.71M31.33%-7.95M-10.81%-2.3M32.52%-1.74M51.93%-1.65M35.25%-2.27M2.82%-11.57M31.57%-2.07M
Minority interest income
Net income attributable to the parent company 14.62%-1.48M-24.48%-2.05M-19.63%-2.71M31.33%-7.95M-10.81%-2.3M32.52%-1.74M51.93%-1.65M35.25%-2.27M2.82%-11.57M31.57%-2.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.62%-1.48M-24.48%-2.05M-19.63%-2.71M31.33%-7.95M-10.81%-2.3M32.52%-1.74M51.93%-1.65M35.25%-2.27M2.82%-11.57M31.57%-2.07M
Basic earnings per share 60.66%-0.2454.55%-0.456.30%-0.5964.59%-2.962.19%-0.49965.92%-0.6165.08%-0.8847.06%-1.3518.51%-8.1945.00%-1.32
Diluted earnings per share 60.66%-0.2454.55%-0.456.30%-0.5964.59%-2.962.19%-0.49965.92%-0.6165.08%-0.8847.06%-1.3518.51%-8.1945.00%-1.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More